Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sana Biotechnology, Inc.

5.56
+0.530010.54%
Post-market: 5.600.0400+0.72%19:59 EDT
Volume:8.62M
Turnover:47.62M
Market Cap:1.43B
PE:-5.22
High:5.69
Open:5.19
Low:5.12
Close:5.03
52wk High:7.30
52wk Low:1.26
Shares:257.00M
Float Shares:166.00M
Volume Ratio:0.67
T/O Rate:5.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0643
EPS(LYR):-1.1553
ROE:-109.12%
ROA:-26.30%
PB:11.66
PE(LYR):-4.81

Loading ...

Sana Biotechnology (SANA): Evaluating Valuation After Breakthrough Islet Cell Therapy and Surge in Market Interest

Simply Wall St.
·
Yesterday

Sana Biotechnology (SANA) Is Up 19.2% After Insulin Breakthrough in Diabetes Program and Strategic Refocus

Simply Wall St.
·
Oct 17

Small U.S. Stocks Rise; Sana Biotechnology Leads Increases

Dow Jones
·
Oct 16

Sana Biotech Stock — The Next '100-Bagger'?

Benzinga_recent_news
·
Oct 16

Sana Biotechnology Has Long-Term Growth Potential on Diabetes, CAR-T Therapies, Wedbush Says

MT Newswires Live
·
Sep 24

Sana Biotechnology Initiated at Outperform by Wedbush

Dow Jones
·
Sep 24

Sana Biotechnology Inc : Wedbush Initiates Coverage With Outperform Rating: Target Price $5

THOMSON REUTERS
·
Sep 24

Sana Biotechnology initiated with an Outperform at Wedbush

TIPRANKS
·
Sep 24

Wedbush Initiates Sana Biotechnology at Outperform With $5 Price Target

MT Newswires Live
·
Sep 24

Sana Biotechnology Announces Upcoming Leadership Change with Aaron M. Grossman as New Chief Legal Officer

Reuters
·
Sep 05

Mary Agnes Wilderotter Resigns from Sana Biotechnology Inc.'s Board of Directors

Reuters
·
Aug 30

Sana Biotechnology to Present at September 2025 Investor Conferences

GlobeNewswire
·
Aug 27

Sana Biotechnology Secures $86.3 Million from Secondary Offering with Full Exercise of Underwriters' Option

Reuters
·
Aug 21

Stock Track | Sana Biotechnology Soars 5.14% on Bullish Analyst Ratings and Promising Advances

Stock Track
·
Aug 12

Stock Track | Sana Biotechnology Soars 5.14% as Analysts Maintain Buy Ratings on Promising Advances

Stock Track
·
Aug 12

Sana Biotechnology Q2 Adj. EPS $(0.16) Beats $(0.21) Estimate

Benzinga
·
Aug 12

BRIEF-Sana Biotechnology Q2 Adjusted EPS USD -0.16 Vs. IBES Estimate USD -0.21

Reuters
·
Aug 12

Sana Biotechnology Q2 Net Income USD -93.8 Million

THOMSON REUTERS
·
Aug 12

Sana Biotechnology Q2 EPS USD -0.39

THOMSON REUTERS
·
Aug 12

Sana Biotechnology Q2 Operating Expenses USD 94.975 Million

THOMSON REUTERS
·
Aug 12